scispace - formally typeset
P

Philip Stegmaier

Researcher at Russian Academy of Sciences

Publications -  27
Citations -  2772

Philip Stegmaier is an academic researcher from Russian Academy of Sciences. The author has contributed to research in topics: TRANSFAC & Promoter. The author has an hindex of 11, co-authored 27 publications receiving 2480 citations.

Papers
More filters
Journal ArticleDOI

TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes

TL;DR: The TRANSFAC® database on transcription factors, their binding sites, nucleotide distribution matrices and regulated genes as well as the complementing database TRANSCompel® on composite elements have been further enhanced on various levels.
Journal ArticleDOI

Systematic DNA-binding domain classification of transcription factors.

TL;DR: A library of hidden Markov models (HMM) to represent their DNA-binding domains was developed and applied on the UniProt/Swiss-Prot database, leading to a systematic classification of further DNA- binding protein entries.
Journal ArticleDOI

“Upstream Analysis”: An Integrated Promoter-Pathway Analysis Approach to Causal Interpretation of Microarray Data

TL;DR: A state-of-the-art promoter analysis for potential transcription factor binding sites in combination with a knowledge-based analysis of the upstream pathway that control the activity of these TFs is shown to lead to hypothetical master regulators.
Journal ArticleDOI

Composite Module Analyst: identification of transcription factor binding site combinations using genetic algorithm

TL;DR: A novel software tool aiming to identify promoter-enhancer models based on the composition of transcription factor (TF) binding sites and their pairs using the positional weight matrix (PWM) library collected in TRANSFAC® and therefore provides the possibility to search for a large variety of different TF binding sites.
Journal ArticleDOI

Multi-omics "upstream analysis" of regulatory genomic regions helps identifying targets against methotrexate resistance of colon cancer.

TL;DR: In this article, an upstream analysis strategy for causal analysis of multiple "omics" data is presented, which analyzes promoters using the TRANSFAC database, combines it with an analysis of the upstream signal transduction pathways and identifies master regulators as potential drug targets for a pathological process.